Susquehanna International Group, LLP Pmv Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$1.23 - $6.6 $307,992 - $1.65 Million	-250,400 Reduced 88.08%	33,900 $105,000
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $1.6 Million - $2.38 Million	266,700 Added 1515.34%	284,300 $1.75 Million
Q2 2023 Aug 11, 2023	SELL	$3.94 - $6.27 $62,252 - $99,066	-15,800 Reduced 47.31%	17,600 $110,000
Q1 2023 May 16, 2023	SELL	$4.77 - $9.16 $354,410 - $680,588	-74,300 Reduced 68.99%	33,400 $159,000
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $624,188 - $989,380	76,400 Added 244.09%	107,700 $936,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $135,660 - $204,442	-11,900 Reduced 27.55%	31,300 $372,000
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $225,212 - $547,292	-24,400 Reduced 36.09%	43,200 $616,000
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $1 Million - $1.59 Million	67,600 New	67,600 $1.41 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.